WO2024144896 - METHODS AND COMPOSITIONS FOR A PLASMA METABOLITE-BASED TEST TO DETECT MINIMAL RESIDUAL DISEASE IN POST-SURGERY COLORECTAL CANCER PATIENTS
National phase entry is expected:
Publication Number
WO/2024/144896
Publication Date
04.07.2024
International Application No.
PCT/US2023/064962
International Filing Date
24.03.2023
Title **
[English]
METHODS AND COMPOSITIONS FOR A PLASMA METABOLITE-BASED TEST TO DETECT MINIMAL RESIDUAL DISEASE IN POST-SURGERY COLORECTAL CANCER PATIENTS
[French]
PROCÉDÉS ET COMPOSITIONS POUR UN TEST BASÉ SUR DES MÉTABOLITES PLASMATIQUES POUR DÉTECTER UNE MALADIE RÉSIDUELLE MINIMALE CHEZ DES PATIENTS ATTEINTS D'UN CANCER COLORECTAL POST-CHIRURGIE
Applicants **
MPROBE INC.
3000 El Camino Real
Bldg 4 Sutie 200
Palo Alto, California 94306, US
TIANJIN YUNJIAN MEDICAL TECHNOLOGY CO., LTD.
No. 39, Gaoxin 6th Road, Binhai high tech Zone
Tianjin, Tianjin 300451, CN
BINHAI INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE OF ZHEJIANG UNIVERSITY
No. 39, Gaoxin sixth Road,Binhai High-tech Industrial Development Area
Tianjin, Tianjin 300000, CN
Inventors
CHEN, Limin
3000 El Camino Real
Bldg 4 Sutie 200
Palo Alto, California 94306, US
Priority Data
63/477,956
30.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1040 | |
| EPO | Filing, Examination | 7209 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2880 |
Total: 12295 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Colorectal Cancer (CRC) Minimal Residual Disease (MRD) markers, CRC MRD marker panels, and methods for obtaining a CRC MRD marker level representation for a sample are provided. These compositions and methods find use in several applications, including, for example, detecting MRD in post-surgery CRC patients, and prognosing colorectal cancer relapse.[French]
L'invention concerne des marqueurs de maladie résiduelle minimale (MRD) du cancer colorectal (CRC), des panels de marqueurs MRD CRC, et des procédés d'obtention d'une représentation au niveau marqueurs MRD CRC pour un échantillon. Ces compositions et procédés trouvent une utilisation dans plusieurs applications, y compris, par exemple, la détection de MRD chez des patients atteints de CRC post-chirurgie, et le pronostic de la rechute du cancer colorectal.